Amarin Corporation PLC
501 articles about Amarin Corporation PLC
-
Amarin Corporation PLC to Host Conference Call at 8:30 a.m. EST on November 29, 2010, to Discuss Top-Line Results of Phase 3 MARINE Study of AMR101 in Patients with Very High Triglycerides
11/29/2010
-
Amarin Corporation PLC to Present at Lazard Capital Markets Annual Healthcare Conference
11/15/2010
-
Amarin Corporation PLC to Host Investor Conference Call on Wednesday, November 10, 2010
11/10/2010
-
Amarin Corporation PLC Reports Third Quarter 2010 Financial Results and Positively Updates Phase 3 Guidance
11/10/2010
-
Amarin Corporation PLC Names Chairman Joseph S. Zakrzewski as CEO
11/10/2010
-
Amarin Corporation PLC to Present at Oppenheimer Annual Healthcare Conference
10/28/2010
-
Amarin Corporation PLC to Present at NewsMakers in the Biotech Industry Conference
10/18/2010
-
Amarin Corporation PLC Appoints Colin W. Stewart as President and Chief Executive Officer
8/17/2010
-
Amarin Corporation PLC's AMR101 Pivotal Phase 3 MARINE Clinical Trial Completes Patient Enrollment and Randomization
8/10/2010
-
Amarin Corporation PLC Reports Q2 2010 Results
8/10/2010
-
Amarin Corporation PLC to Host Investor Conference Call on Tuesday, August 10, 2010
8/3/2010
-
Amarin Corporation PLC to Present at Canaccord Genuity Global Growth Conference
7/30/2010
-
Amarin Corporation PLC to Present at Two Upcoming Investor Conferences
6/4/2010
-
Amarin Corporation PLC to Present at the Rodman & Renshaw Global Investment Conference
5/14/2010
-
Amarin Corporation PLC Reports Q1 2010 Results
5/13/2010
-
Amarin Corporation PLC to Host Investor Conference Call on Thursday, May 13, 2010
5/12/2010
-
Amarin Corporation PLC to Present at the Deutsche Bank Securities Health Care Conference
4/28/2010
-
Amarin Corporation PLC to Present at the Cowen and Company Healthcare Conference
3/3/2010
-
Amarin Corporation PLC Appoints Jan van Heek Non-Executive Director
2/11/2010
-
Amarin Corporation PLC Provides 2009 Year-End Review to Shareholders
1/28/2010